Literature DB >> 33475702

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.

Tom Shimabukuro1, Narayan Nair2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33475702      PMCID： PMC8892260          DOI： 10.1001/jama.2021.0600

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Jens U Rüggeberg; Michael S Gold; José-Maria Bayas; Michael D Blum; Jan Bonhoeffer; Sheila Friedlander; Glacus de Souza Brito; Ulrich Heininger; Babatunde Imoukhuede; Ali Khamesipour; Michel Erlewyn-Lajeunesse; Susana Martin; Mika Mäkelä; Patricia Nell; Vitali Pool; Nick Simpson
Journal:  Vaccine       Date:  2007-03-12       Impact factor: 3.641

Review 2.  Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Tom T Shimabukuro; Michael Nguyen; David Martin; Frank DeStefano
Journal:  Vaccine       Date:  2015-07-22       Impact factor: 3.641

Review 3.  Vaccine-associated hypersensitivity.

Authors:  Michael M McNeil; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2018-02       Impact factor: 10.793

4.  Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-15       Impact factor: 17.586

5.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-18       Impact factor: 17.586

6.  Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.

Authors:  Lauren M Rossen; Amy M Branum; Farida B Ahmad; Paul Sutton; Robert N Anderson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-10-23       Impact factor: 17.586
  6 in total
  100 in total

1.  Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2.

Authors:  Eli Magen; Avi Yakov; Ilan Green; Ariel Israel; Shlomo Vinker; Eugene Merzon
Journal:  Allergy Asthma Proc       Date:  2022-01-01       Impact factor: 2.587

Review 2.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

3.  Association of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA vaccine short-term adverse reactions in healthcare workers.

Authors:  Filippos Filippatos; Elizabeth-Barbara Tatsi; Charilaos Dellis; Nick Dessypris; Vassiliki Syriopoulou; Athanasios Michos
Journal:  Hum Vaccin Immunother       Date:  2021-11-30       Impact factor: 3.452

4.  Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

Authors:  Tom T Shimabukuro; Matthew Cole; John R Su
Journal:  JAMA       Date:  2021-03-16       Impact factor: 56.272

Review 5.  Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2.

Authors:  Ian McDonald; Sam M Murray; Catherine J Reynolds; Daniel M Altmann; Rosemary J Boyton
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

Review 6.  mRNA-Based Vaccines.

Authors:  Frank Kowalzik; Daniel Schreiner; Christian Jensen; Daniel Teschner; Stephan Gehring; Fred Zepp
Journal:  Vaccines (Basel)       Date:  2021-04-15

Review 7.  An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.

Authors:  Cielo García-Montero; Oscar Fraile-Martínez; Coral Bravo; Diego Torres-Carranza; Lara Sanchez-Trujillo; Ana M Gómez-Lahoz; Luis G Guijarro; Natalio García-Honduvilla; Angel Asúnsolo; Julia Bujan; Jorge Monserrat; Encarnación Serrano; Melchor Álvarez-Mon; Juan A De León-Luis; Miguel A Álvarez-Mon; Miguel A Ortega
Journal:  Vaccines (Basel)       Date:  2021-04-27

8.  Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers.

Authors:  Antonella d'Arminio Monforte; Alessandro Tavelli; Pier Mario Perrone; Alessandro Za; Katia Razzini; Daniele Tomasoni; Vittorio Bordoni; Luisa Romanò; Nicola Orfeo; Giulia Marchetti; Claudio Colosio
Journal:  EClinicalMedicine       Date:  2021-05-31

9.  COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.

Authors:  Gang Chen; Xiaolin Li; Meixing Sun; Yangzhong Zhou; Meifang Yin; Bin Zhao; Xuemei Li
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

10.  Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.

Authors:  Barbara H Bardenheier; Stefan Gravenstein; Carolyn Blackman; Roee Gutman; Indra Neil Sarkar; Richard A Feifer; Elizabeth M White; Kevin McConeghy; Aman Nanda; Vincent Mor
Journal:  Vaccine       Date:  2021-05-28       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.